These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 35054412)

  • 21. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
    Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
    Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Aberrant Case of Neuromyelitis Optica Spectrum Disorder With a Review of Literature.
    Dhok A; Ratnaparkhi C; Kumar S; Manhas SD; Umredkar A
    Cureus; 2024 May; 16(5):e59765. PubMed ID: 38846197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiological identification of neuromyelitis optica in a patient presented with unexplained weight loss and generalized weakness: a case report and literature review.
    Shrateh ON; Jobran AWM; Khaled Z; Zaid MA; Dallashi AA
    Ann Med Surg (Lond); 2023 Jun; 85(6):3145-3148. PubMed ID: 37363580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromyelitis optica, aquaporin-4 antibodies, and neuroendocrine disorders.
    Iorio R; Papi C
    Handb Clin Neurol; 2021; 181():173-186. PubMed ID: 34238456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
    Topuzova MP; Bisaga GN; Alekseeva TM; Isabekova PS; Сhaykovskaya AD; Panina EB; Pavlova TA; Ternovykh IK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):97-106. PubMed ID: 32844638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
    van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
    Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
    Clarke L; Arnett S; Lilley K; Liao J; Bhuta S; Broadley SA
    Clin Exp Immunol; 2021 Dec; 206(3):251-265. PubMed ID: 34080180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.
    de Seze J
    Curr Opin Neurol; 2019 Feb; 32(1):111-114. PubMed ID: 30562266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.
    Ungureanu A; de Seze J; Ahle G; Sellal F
    Rev Neurol (Paris); 2018 Dec; 174(10):675-679. PubMed ID: 30293882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double Seronegative Neuromyelitis Optica Spectrum Disorder with Longitudinally Extensive Transverse Myelitis and Optic Neuritis: A Challenging Case Report.
    Chon Han G; Iqbal T; Supramaniam G
    Cureus; 2024 Mar; 16(3):e57044. PubMed ID: 38681400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis of neuromyelitis optica spectrum disorders.
    Kim SM; Kim SJ; Lee HJ; Kuroda H; Palace J; Fujihara K
    Ther Adv Neurol Disord; 2017 Jul; 10(7):265-289. PubMed ID: 28670343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide.
    Hor JY; Asgari N; Nakashima I; Broadley SA; Leite MI; Kissani N; Jacob A; Marignier R; Weinshenker BG; Paul F; Pittock SJ; Palace J; Wingerchuk DM; Behne JM; Yeaman MR; Fujihara K
    Front Neurol; 2020; 11():501. PubMed ID: 32670177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
    de Sèze J; Kremer L; Collongues N
    Rev Neurol (Paris); 2016; 172(4-5):256-62. PubMed ID: 27157418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The distinction of area postrema syndrome between MOGAD and NMOSD.
    Chen Y; Zhangbao J; Xu J; Zhou L; Zhou Z; Quan C
    Heliyon; 2024 May; 10(10):e30633. PubMed ID: 38779012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
    Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Pediatric NMOSD in Germany and Austria.
    Lechner C; Breu M; Wendel EM; Kornek B; Schanda K; Baumann M; Reindl M; Rostásy K
    Front Neurol; 2020; 11():415. PubMed ID: 32670175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.